TrialRespiratory research2019

Efficacy and safety of AZD7594, an inhaled non-steroidal selective glucocorticoid receptor modulator, in patients with asthma: a phase 2a randomized, double blind, placebo-controlled crossover trial.

Mary N Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.